
E-7386
CAS No. 1799824-08-0
E-7386( E7386 )
Catalog No. M12730 CAS No. 1799824-08-0
E-7386 (E7386) is a potent, orally active modulator of CBP/beta-catenin.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 242 | In Stock |
![]() ![]() |
10MG | 368 | In Stock |
![]() ![]() |
25MG | 614 | In Stock |
![]() ![]() |
50MG | 872 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameE-7386
-
NoteResearch use only, not for human use.
-
Brief DescriptionE-7386 (E7386) is a potent, orally active modulator of CBP/beta-catenin.
-
DescriptionE-7386 (E7386) is a potent, orally active modulator of CBP/beta-catenin, disrupts the interaction and inhibits canonical Wnt signaling pathway /TCF reporter gene activity in LiCl-stimulated HEK-293 and MDA-MB-231 with IC50 of 55 and 73 nM, respectively; exhibits anti-tumor activity in vitro tumor proliferation panel against 28 human tumor cell lines; modulates the expression of Wnt signaling pathway related genes including AXIN2 and other genes, significantly suppressed the number of polyposis in a dose dependent manner at the dose 8.5-50 mg/kg, also significantly changed the expressions of Wnt related genes in whisker follicle of ApcMin/+mice model.
-
In Vitro——
-
In VivoE-7386 is an orally active CBP/beta-catenin modulator which can induce T cells infiltration into tumor and enhance antitumor activity of anti-PD-1 mAb in Wnt1 tumor syngeneic mice model. E-7386 shows significant antitumor activity in Wnt1 model.Infiltration of T cells is limited in vehicle control group, but T cell infiltration into tumors is clearly observed in E-7386 treatment group.
-
SynonymsE7386
-
PathwayWnt/Notch/Hedgehog
-
TargetBeta-catenin
-
RecptorBeta-catenin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1799824-08-0
-
Formula Weight725.87
-
Molecular FormulaC39H48FN9O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (172.21 mM)
-
SMILESCCN1CCN(CC1)C2CN(C2)C3=CC=CC(=N3)CN4CC5N(C(C4=O)CC6=C(C=C(C=C6)O)F)C(=O)CN(N5C(=O)NCC7=CC=CC=C7)CC=C
-
Chemical Name(6S,9aS)-2-allyl-N-benzyl-8-((6-(3-(4-ethylpiperazin-1-yl)azetidin-1-yl)pyridin-2-yl)methyl)-6-(2-fluoro-4-hydroxybenzyl)-4,7-dioxohexahydro-2H-pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kazuhiko Yamada, et al. Abstract 5177: E7386 : First-in-class orally active CBP/beta-catenin modulator as an anticancer agent. AACR 2017.
molnova catalog



related products
-
PNU-74654
A novel potent Wnt/beta-catenin inhibitor by disrupting Tcf/β-catenin interaction; binds to β-catenin with Kd of 450 nM.
-
CCT-031374
CCT-031374 is a selective β-catenin signaling inhibitor with IC50 of 6.1 uM.
-
CCT-031374 hydrobrom...
A novel small-molecule Wnt signaling inhibitor that inhibits TCF-dependent transcription with IC50 of 6.1 uM in 7dF3 reporter assay.